The Korean journal of internal medicine

  • 제33권5호
  • /
  • Pages.879-882
  • /
  • 2018
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

The euphoria, the warnings and the downfall of the current bioresorbale stents: could the journey be restarted?

  • Kounis, Nicholas G. (Department of Cardiology, University of Patras Medical School) ;
  • Koniari, Ioanna (Department of Cardiology, Royal Bromptom Hospital) ;
  • Chourdakis, Emmanouil (Krankenhaus der Barmherzigen Bruder Trier) ;
  • Velissaris, Dimitrios (Department of Internal Medicine, University of Patras Medical School) ;
  • Hahalis, George (Department of Cardiology, University of Patras Medical School)
  • 투고 : 2018.02.12
  • 심사 : 2018.04.04
  • 발행 : 2018.09.01
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Kwon O, Ahn JM, Kang DY, et al. Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea. Korean J Intern Med 2018;33:922-932. https://doi.org/10.3904/kjim.2016.368
  2. Tamai H, Igaki K, Kyo E, et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000;102:399-404. https://doi.org/10.1161/01.CIR.102.4.399
  3. Ormiston JA, Serruys PW, Regar E, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 2008;371:899-907. https://doi.org/10.1016/S0140-6736(08)60415-8
  4. Onuma Y, Serruys PW, Ormiston JA, et al. Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention 2010;6:447-453. https://doi.org/10.4244/EIJ30V6I4A76
  5. Onuma Y, Dudek D, Thuesen L, et al. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. JACC Cardiovasc Interv 2013;6:999-1009. https://doi.org/10.1016/j.jcin.2013.05.017
  6. Ho HH, Er Ching M, Ong PJ, Ooi YW. Subacute bioresorbable vascular scaffold thrombosis: a report of 2 cases. Heart Vessels 2015;30:545-548. https://doi.org/10.1007/s00380-014-0513-8
  7. Kounis NG, Soufras GD, Tsigkas G, Hahalis G. Bioabsorbable stent thrombosis Quo Vadis: is Kounis syndrome still present? Int J Cardiol 2014;176:305-306. https://doi.org/10.1016/j.ijcard.2014.07.227
  8. Lendlein A, Langer R. Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science 2002;296:1673-1676. https://doi.org/10.1126/science.1066102
  9. Bostman O, Pihlajamaki H. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials 2000;21:2615-2621. https://doi.org/10.1016/S0142-9612(00)00129-0
  10. Ji W, Yang F, Seyednejad H, et al. Biocompatibility and degradation characteristics of PLGA-based electrospun nanofibrous scaffolds with nanoapatite incorporation. Biomaterials 2012;33:6604-6614. https://doi.org/10.1016/j.biomaterials.2012.06.018
  11. Kounis NG, Koniari I, Tsigkas G, Soufras GD, Hahalis G. Where are the secrets of increased thrombosis and aneurysm formation with the current bioresorbable vascular scaffolds hidden? Circ J 2018;82:608-609. https://doi.org/10.1253/circj.CJ-17-0946
  12. Kounis NG, Koniari I, Davlouros P, Soufras G, Tsigkas G, Hahalis G. Bioresorbable stents: quo vantis? J Thorac Dis 2017;9:E1032-E1034. https://doi.org/10.21037/jtd.2017.10.62
  13. Wykrzykowska JJ, Kraak RP, Hofma SH, et al. Bioresorbable scaffolds versus metallic stents in routine PCI. N Engl J Med 2017;376:2319-2328. https://doi.org/10.1056/NEJMoa1614954
  14. Ali ZA, Serruys PW, Kimura T, et al. 2-Year outcomes with the absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet 2017;390:760-772. https://doi.org/10.1016/S0140-6736(17)31470-8
  15. Sorrentino S, Giustino G, Mehran R, et al. Everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents. J Am Coll Cardiol 2017;69:3055-3066. https://doi.org/10.1016/j.jacc.2017.04.011